SUPERNUS PHARMACEUTICALS, INC.·4

Feb 25, 4:56 PM ET

Hudson Frederick M. 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 25, 2026

Insider Transaction Report

Form 4
Period: 2026-02-24
Transactions
  • Award

    Common Stock

    2026-02-24+4,47565,782 total
  • Disposition to Issuer

    Restricted Stock Unit

    [F1][F2]
    2026-02-244,4750 total
    Common Stock (4,475 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-02-25

Documents

1 file
  • 4
    wk-form4_1772056609.xmlPrimary

    FORM 4